Acro Biomedical (ACBM) Operating Expenses (2015 - 2025)
Acro Biomedical's quarterly Operating Expenses came in at $16377.0 in Q4 2025, up 72.97% year-on-year from $9468.0 in Q4 2024, and down 85.77% quarter-over-quarter from $115099.0 in Q3 2025.
Acro Biomedical has reported Operating Expenses for 11 years, with the latest figure at $16377.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses rose 72.97% year-over-year to $16377.0; the trailing twelve-month figure through Dec 2025 stood at $154024.0 (up 305.77% YoY), and the FY2025 full-year result was $154024.0, up 305.77% from the prior year.
- Operating Expenses for Q4 2025 stood at $16377.0, down from $115099.0 in the prior quarter.
- The five-year high for Operating Expenses was $4.0 million in Q3 2022, with the low at $8934.0 in Q1 2025.
- Average Operating Expenses over 5 years is $1.6 million, with a median of $494209.5 recorded in 2021.
- Year-over-year, Operating Expenses surged 4530.64% in 2022 and sank 99.74% in 2024.
- Tracing ACBM's Operating Expenses over 5 years: stood at $4.0 million in 2021, then decreased by 0.12% to $4.0 million in 2022, then plunged by 99.56% to $17401.0 in 2023, then slumped by 45.59% to $9468.0 in 2024, then surged by 72.97% to $16377.0 in 2025.
- The last three Operating Expenses figures came in at $16377.0 (Q4 2025), $115099.0 (Q3 2025), and $13614.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 427,850.00 |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 482,100.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 201,744.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 1.15 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 612,993.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 218,386.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 198,194.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 811,301.00 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 168,092.00 |
| 10 | Acro Biomedical | - | - | - | 16,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16,377.00 |
| Sep 30, 2025 | 115,099.00 |
| Jun 30, 2025 | 13,614.00 |
| Mar 31, 2025 | 8,934.00 |
| Dec 31, 2024 | 9,468.00 |
| Sep 30, 2024 | 9,106.00 |
| Jun 30, 2024 | 9,086.00 |
| Mar 31, 2024 | 10,298.00 |
| Dec 31, 2023 | 17,401.00 |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 3.19 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 4.01 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 2.99 Mn |
| Jun 30, 2021 | 873,320.00 |
| Mar 31, 2021 | 86,491.00 |
| Sep 30, 2020 | 71,541.00 |
| Jun 30, 2020 | 62,771.00 |
| Mar 31, 2020 | 77,847.00 |
| Dec 31, 2019 | 87,529.00 |
| Sep 30, 2019 | 64,460.00 |
| Jun 30, 2019 | 68,092.00 |
| Mar 31, 2019 | 214,766.00 |
| Dec 31, 2018 | 229,635.00 |
| Sep 30, 2018 | 91,514.00 |
| Jun 30, 2018 | 63,674.00 |
| Mar 31, 2018 | 98,389.00 |
| Dec 31, 2017 | 64,273.00 |
| Sep 30, 2017 | 11,505.00 |
| Jun 30, 2017 | 11,887.00 |
| Mar 31, 2017 | 22,443.00 |
| Dec 31, 2016 | 7,413.00 |
| Sep 30, 2016 | 6,127.00 |
| Jun 30, 2016 | 17,125.00 |
| Mar 31, 2016 | 6,350.00 |
| Dec 31, 2015 | 13,826.00 |
| Sep 30, 2015 | 2,337.00 |